Associations of fibroblast growth factor-23 with markers of inflammation, insulin resistance and obesity in adults.
Elevated fibroblast growth factor-23 (FGF23) is an established marker of cardiovascular disease. The underlying reason(s) for the rise accompanying cardiovascular health decline are unclear. Prior studies have shown that FGF23 concentrations are associated with markers of inflammation and insulin re...
Main Authors: | Lynae J Hanks, Krista Casazza, Suzanne E Judd, Nancy S Jenny, Orlando M Gutiérrez |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4374938?pdf=render |
Similar Items
-
Circulating levels of fibroblast growth factor-21 increase with age independently of body composition indices among healthy individuals
by: Lynae J. Hanks, et al.
Published: (2015-06-01) -
Vitamin D, Fibroblast Growth Factor 23 and Incident Cognitive Impairment: Findings from the REGARDS Study.
by: Bhupesh Panwar, et al.
Published: (2016-01-01) -
Iron and obesity status-associated insulin resistance influence circulating fibroblast-growth factor-23 concentrations.
by: José Manuel Fernández-Real, et al.
Published: (2013-01-01) -
Obesity, inflammation, and insulin resistance
by: Luana Mota Martins, et al.
Published: (2014-12-01) -
Fibroblast Growth Factor 23 and Incident Cardiovascular Disease and Mortality in Middle‐Aged Adults
by: Shejuti Paul, et al.
Published: (2021-08-01)